National Healthcare Corp

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $1.88B
  • PE 15
  • Debt $154.50M
  • Cash $115.07M
  • EV $1.92B
  • FCF $92.20M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$123.81M
EBIT$135.41M
ROE13%
ROA9%
FCF$92.20M
Equity$986.80M
Growth Stability24%
PE15.18
PEG2.64
PB1.9
P/FCF20.38
P/S1.52
Price/Cash0.06
Debt/Equity0.16
Debt/FCF1.68
Net Margins10%
Op. Margins11%
Earnings CAGR2%
Sales Growth YoY18%
Sales Growth QoQ13%
Sales CAGR3%
FCF CAGR5%
Equity CAGR4%
Earnings Stability0.01
Earnings Growth YoY323%
Earnings Growth QoQ59%
Earnings CAGR 5Y6%
Sales CAGR 5Y4%
FCF CAGR 5Y-8%
Equity CAGR 5Y5%
Earnings CAGR 3Y4%
Sales CAGR 3Y4%
FCF CAGR 3Y70%
Equity CAGR 3Y2%
Market Cap$1.88B
Revenue$1.24B
Dividend Yield2%
Payout Ratio30%
Assets$1.56B
Total Debt$154.50M
Cash$115.07M
Shares Outstanding15.38M
EV1.92B
Earnings Score6%
Moat Score90%
Safety Score66%
Final Score54%
Working Capital197.78M
Current Ratio1.8
Shares Growth 3y1%
Equity Growth QoQ4%
Equity Growth YoY11%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.

SEC Filings

Direct access to National Healthcare Corp (NHC) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does National Healthcare Corp compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of National Healthcare Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 2%
Stability 1%
loading chart...

National Healthcare Corp Discounted Cash Flow

Fully customizable DCF calculator online for National Healthcare Corp.

= $1.3B
012345678910TV
fcf$92M$97M$102M$107M$113M$119M$125M$131M$138M$145M$152M$1.5B
DCF$88M$84M$81M$77M$74M$70M$67M$64M$61M$59M$588M
Value$1.3B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins5%5%5%6%6%7%4%13%2%6%10%
ROA-6%6%5%5%4%4%4%3%4%9%
ROE-7%8%8%8%9%5%15%2%7%13%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF-4.814.241.610.80.270--01.68
Debt over Equity0.010.190.180.140.070.030--00.16
Growth Stability---100%100%100%69%100%24%98%24%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth-4%2%4%2%2%3%4%1%5%4%
Earnings YoY growth-4%9%10%5%16%-38%231%-86%227%6%
Equity YoY growth--14%6%5%4%6%2%14%-3%4%5%
FCF YoY growth--13%13%120%11%7%146%-87%-193%-488%-8%